MedTrace Logo

Immersive VR for Female Orthopaedic Rehabilitation

NCT06506760 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-03-24

No results posted yet for this study

Summary

This study compares the effects of cardiological rehabilitation enhanced with virtual reality (VR) versus conventional rehabilitation methods. It assesses the impact on both psychological parameters (including depression, stress, anxiety, and kinesiophobia) and physiological and functional parameters of cardiology patients. The aim is to analyze the efficacy and benefits of VR-supported rehabilitation in improving patients' mental and physical health compared to traditional methods.

Conditions

  • Hip Arthropathy

Interventions

BEHAVIORAL

Immersive Virtual Reality Therapy

8 sessions of VR therapy over 4 weeks (each of them 20 minutes long). As a virtual reality source, VRTierOne device (Stolgraf®) were used. Thanks to using head mounted display and the phenomenon of total immersion VR therapy provides an intense visual, auditory and kinesthetic stimulation. It can have a calming and mood-improving effect or help the patients recognize their psychological resources and motivate to the rehabilitation process. In the virtual therapeutic garden there are a rich set of symbols and metaphors based on Ericksonian Psychotherapy approach. The most important is the Garden of Revival which symbolizes the patient's health. It used to be full of life and energy, now it is neglected, requires work to be revived. In the therapeutic process day by day, the therapist tells the patient a symbolic story about his/her situation.

BEHAVIORAL

Conventional rehabilitation

Four weeks of conventional rehabilitation including: Two hours of kinesiotherapy (120 minutes, including gait training). Thirty minutes of ergotherapy. Three physical therapy procedures (i.e. laser therapy, magnetic therapy, electrotherapy) tailored to individual ailments and needs.

Sponsors & Collaborators

  • Wroclaw Medical University

    collaborator OTHER

  • Jan Dlugosz University in Czestochowa

    collaborator OTHER

  • Wroclaw University of Health and Sport Sciences

    lead OTHER

Principal Investigators

  • Justyna Mazurek, PhD · Wroclaw Medical University

  • Joanna Szczepańska-Gieracha, Professor · Wrocław University of Health and Sport Sciences

  • Robert Gajda, PhD · Gajda-Med District Hospital in Pułtusk

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-11
Primary Completion
2024-08-15
Completion
2024-08-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06506760 on ClinicalTrials.gov